Folic Acid Articles
13.7% growth for Indian pharma recorded 13.7%to $9.43 billion in first three quarters of fiscal 2009-10
4 February 2010
Spectrum plunges on FDA letter delaying Fusilev approval in advanced metastatic colorectal cancer
12 October 2009
Folic acid cuts congential heart defects 6%
2 June 2009
Folate supps "double prostate cancer risk"
16 March 2009
AMD risk reduced by Vit B and folic acid
2 March 2009
Only 11% take folic acid before pregnancy
12 January 2009
Study urges Hispanics to take folic acid
12 January 2009
Folate in pregnancy linked to RTIs in infants
15 December 2008
Allos drug gets orphan designation from FDA
1 December 2008
Folic acid "safe but lacks CV health benefits"
17 November 2008
Nutritionists note anti-aging effect of cherries
8 September 2008
Tofu linked to poorer memory, says AD trust
21 July 2008
Polypill cuts 80% of CV deaths in over 55s
12 May 2008
Levoleucovorin gets US OK for osteosarcoma
17 March 2008
Folic acid supps cut premature birth rate
18 February 2008
Meda to acquire Recip for $407M+
5 November 2007
Folic acid supps may cut childhood cancers
3 September 2007
Allos initiates Ph I trial of CTCL drug
20 August 2007
Folic acid can reduce stroke risk
2 July 2007
Folic acid supplement slows cognitive decline
4 June 2007
Folic acid could delay mental decline of aging
19 February 2007
TRx Pharma launches Folmor in the USA
12 February 2007
BMJ paper urges caution on homocysteine
11 December 2006
DHA cuts risk of all-cause dementia 47%
27 November 2006
CRN calls for more CV research on B vitamins
20 November 2006
Allos starts Ph I trial of PDX in NSCLC
31 January 2005
Lilly's Alimta OKed in EU for two indications
27 September 2004
Vit B12 may prevent birth defects
6 September 2004
FDA OKs 2nd indication for Lilly's Alimta
30 August 2004
Promising new data for Lilly's Alimta
28 July 2003
Alimta: first effective mesothelioma drug
27 May 2002
BASF and Takeda to combine vitamin ops
31 July 2000
India moves on bulk drug output, excise
8 February 1999
Nutraceuticals And The Pharma Industry
21 October 1997
Cadila Plans Investment In India
10 February 1997
UK Medicines Control Agency Report For 1995-96
19 August 1996
India Ends Bulk Drug Industrial Licensing
14 November 1994
US Congress passes Vitamin legislation
17 October 1994
SWEDISH PHARMA MARKET GROWTH SLOWDOWN
28 February 1994
FDA ISSUES NEW RULES ON DIETARY SUPPLEMENTS
17 January 1994
NUTRITION LABELING AND EDUCATION IN THE USA
25 October 1993
FDA PROBE INTO VITAMIN HEALTH CLAIMS
12 July 1993
TAKEDA'S TNP-351 IN PHASE II TRIALS
1 February 1993
FOLIC ACID SUPPLEMENTATION
4 January 1993
ANTI-INFECTIVE DRUGS SET FOR GROWTH IN EUROPE
14 December 1992
Showing 1-50 of 50 articles
- 1
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
